Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 37 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Operating Activities:          
Net loss     $ (10,006) $ (13,201)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization [note 3]     191 192  
Stock-based compensation [note 6 [c] and note 6 [d]] $ 281 $ 310 891 917  
Changes in operating assets and liabilities:          
Amounts receivable     8    
Prepaid expenses and other assets     (1,128) 597  
Accounts payable     (533) 430  
Accrued liabilities other     56 (320)  
Accrued clinical liabilities     (294) (462)  
Accrued compensation     (176) 39  
Lease obligation [note 7]     (3) 6  
Net cash used in operating activities     (10,994) (11,802)  
Financing Activities:          
Proceeds from exercise of warrants     3,080 4,199  
Net cash provided by financing activities     16,740 4,622  
Investing Activities:          
Purchase of property and equipment     (17) (52)  
Purchase of investments       (25)  
Proceeds from maturities of investments       5,114  
Net cash provided by (used in) investing activities     (17) 5,037  
Effect of exchange rate changes on cash       3  
Net increase (decrease) in cash, cash equivalents and restricted cash     5,729 (2,140)  
Cash, cash equivalents and restricted cash at beginning of the period     16,714 9,565  
Cash, cash equivalents and restricted cash at end of the period $ 22,443 $ 7,425 22,443 7,425 $ 22,443
LPC [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement         $ (500)
LPC [Member] | Purchase Agreement [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs       $ 423  
Financing costs relating to public offering and purchase agreement     (14)    
April 2020 Financing [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs     1,579    
December 2019 Public Offering [Member]          
Financing Activities:          
Financing costs relating to public offering and purchase agreement     (34)    
July 2020 Registered Direct Offering [Member]          
Financing Activities:          
Proceeds financing and purchase agreement, net of issuance costs     5,307    
August 2020 Public Offering [Member]          
Financing Activities:          
Proceeds from offering, net of issuance costs     $ 6,822